Verily Me: A Practical Consumer App With Clinician-Reviewed Insights
Dallas-based precision health AI company Verily has introduced Verily Me-a consumer health app built to close care gaps and keep people engaged with their health over time. The launch follows Verily's relocation from San Francisco to Dallas and continues its push to connect data, care teams, and patients in one place.
"We created Verily Me to meet the consumer need for a simpler, more personalized healthcare solution," said Dr. Vindell Washington, chief clinical officer at Verily. The app surfaces insights from health records and offers clinician-guided recommendations to help people manage their health more confidently.
What the App Offers
- Unified health history: Licensed clinicians review medical records across multiple providers and health systems, then deliver personalized care recommendations inside the app.
- Record-aware AI: Violet, a private AI companion, can answer questions like "When was my last flu vaccination?" or "Who performed my knee surgery last year?" in a secure setting.
- Photo-based meal tracking: Users can snap meal photos to get real-time feedback and nutrition tips.
- Research participation: Opt-in access to Verily's Lifelong Health Study to contribute real-world data.
Why This Matters for Care Teams
According to a new Harris Poll survey sponsored by Verily, 75% of Americans want an app that provides personalized recommendations from a healthcare provider and helps them make sense of their health over time. Verily Me is positioned to reduce friction in pre-visit planning, medication reconciliation, and care plan adherence by pairing consolidated data with clinician oversight.
For providers, that means clearer context during visits, fewer gaps in documentation, and more actionable follow-ups. Patients get guidance they can understand, and teams get signals they can act on.
Clinical Model and Program Integration
The app integrates with Verily's Lightpath personalized care program, offered through employers, payers, and PBMs. Members receive tiered clinical support based on need, with escalation to physicians, pharmacists, and registered dietitians when clinically indicated.
Lightpath currently focuses on cardiometabolic care-supporting people with Type 1 and Type 2 diabetes, pre-diabetes, obesity, and related conditions. The goal is a more data-driven process where patients and providers can share and act on information with less back-and-forth.
Data Platform and Security Notes
Verily Me is built on Verily's precision health platform, Pre, which transforms complex, multimodal datasets for use across AI-enabled care. Violet, the in-app AI companion, operates in a private setting and answers record-specific questions to help users find what matters quickly.
For clinical teams, this setup could streamline chart reviews and reduce patient uncertainty between visits-without adding extra portals or manual data entry.
Access and Availability
The app is in beta and available in the Apple and Google Play app stores. Verily highlighted Verily Me at HLTH USA 2025, signaling broader ecosystem interest in consumer-grade tools that plug into clinical workflows.
Research Footprint
Earlier this year, Verily received a $14.7 million grant from The Michael J. Fox Foundation for Parkinson's research-an example of its ongoing investment in data-driven research and translational initiatives. That research mindset shows up in Verily Me through the optional Lifelong Health Study and the company's emphasis on real-world data.
The Michael J. Fox Foundation has been a leading funder of Parkinson's research and an advocate for high-quality data collection in the field.
Practical Takeaways for Healthcare Teams
- Evaluate fit: Identify where clinician-reviewed recommendations and unified health history could reduce admin load or improve care coordination in your setting.
- Plan integrations: Clarify data sources, record-matching rules, and how insights flow back to your EHR and care team workflows.
- Set governance: Define escalation criteria, documentation standards, and quality measures for Lightpath and non-Lightpath populations.
- Address consent and education: Make it easy for patients to understand what's being shared, how Violet works, and what to expect from recommendations.
- Measure impact: Track visit efficiency, adherence, and condition-specific outcomes-especially for cardiometabolic cohorts.
For more on Verily's broader platform and initiatives, see Verily.
Your membership also unlocks:
